William Blair starts coverage on Compass Therapeutics, saying its lead drug could reshape bile duct cancer treatment and ...

Link Academy (Miss.) takes the No. 1 spot to start the calendar year, with Spire Academy (Ohio) making the biggest jump to No ...

Since 2018, over 2,100 trafficking victims have been identified in three Oregon counties, with half being minors when first ...

Maryland unveils Community Business Compass with data tools and $10M in funding to boost child care and fresh food access.

William Blair initiated coverage of Compass Therapeutics (CMPX) with an Outperform rating and no price target The firm cites the potential success ...

Sixty-two children woke up with gifts under the tree on Christmas morning thanks to generous donations from those in the ...

On December 3, 2025, Compass Therapeutics, Inc. (NASDAQ:CMPX) saw Canaccord analyst John Newman initiate coverage of the stock with a “Buy” rating and a $10 price target.

Note: The FAB 50 powered by Ballislife.com is a continuation of the National Sports News Service ratings that began in 1952.

Bangladesh protests live updates | Protest outside Puri Jagannath temple over lynching of Hindus Why is Nandi always facing ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

The Performing Arts Project’s Compass: Dance for Movers summer program provides extraordinary beginner to beginner/intermediate-level dance technique training with Broadway and industry professionals ...